Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Researchers find DMT an ‘increasingly popular’ psychedelic drug

by Eric W. Dolan
November 30, 2013
in Psychopharmacology
Share on TwitterShare on Facebook

Dimethyltryptamine moleculeThe illegal drug known as N,N-dimethyltryptamine (DMT) appears to be increasing in popularity, but is relatively safe, according to research published in the Journal of Psychopharmacology in November.

“The ratio of users for whom DMT was the last new drug versus those who reported lifetime DMT use was higher than ketamine, LSD and magic mushrooms, suggesting that it may be an increasingly popular substance for those seeking an alternative to traditionally available hallucinogens,” Dr. Adam R. Winstock of King’s College London and his colleagues wrote in the study.

DMT was first synthesized by the chemist Richard H. F. Manske in 1931. The drug’s powerful psychedelic properties were not scientifically documented until psychiatrist Stephen Szára studied DMT in the mid-1950s. Researchers later discovered the drug occurred naturally in the human body.

Though the scientific institutions of the West only recently discovered DMT, the drug was the key component of a sacred brew called ayahausca or yage that had a long history of use by South American tribes.

Winstock and his colleagues used the Global Drug Survey to compare DMT with ketamine, LSD and magic mushrooms. The survey included more than 22,000 respondents from around the world. About two percent, or 472 participants, reported that DMT was the last new drug they had tried.

Those who recently started using the drug were more likely to be younger, male and currently in education when compared with those who never used DMT.

For all the psychedelic substances, the most common source was a friend. A drug dealer was the second most common source.

DMT users said the drug provided “a short, intense and pleasurable experience with negligible negative effects.”

Google News Preferences Add PsyPost to your preferred sources

The vast majority smoked DMT and for most people the effects only lasted about 15 minutes. The majority of users also rated the effect of DMT as stronger than ketamine, magic mushrooms and LSD.

“Such potency of effect should prompt novice users to take significant care and advice when first using this drug since the rapid onset of an intense psychedelic effect may be unpleasant,” the researchers noted.

Few people felt an urge to use more of the drug. The researchers concluded that DMT “has a reasonable safety profile, with few users reporting significant negative effects when high or following an episode of use.” The median lethal dose of DMT in humans is estimated to be about 560 mg, which is 20 times a normal dose.

The harms associated with the drug are due to “bad trips,” or disturbing hallucinatory experiences. Some users also reported respiratory irritation.

“Like other psychedelic substances, DMT’s profound effects on consciousness may limit its appeal to the wider population and likely prevent habitual use, except in those who use it in within a religious context,” the researchers said.

The drug’s subjective effects were featured in the cult film Enter the Void. Watch below:

Previous Post

Who are you looking at? Why women recognise more faces than men

Next Post

Time flies when you are looking at an unattractive face

RELATED

New psychology research flips the script on happiness and self-control
Cannabis

Exploring the motivations for cannabis use during sex

March 4, 2026
Chocolate lovers’ brains: How familiarity influences reward processing
Cognitive Science

A single dose of cocoa flavanols improves cognitive performance during aerobic exercise

March 4, 2026
Scientists discover psychedelic drug 5-MeO-DMT induces a state of “paradoxical wake”
Ayahuasca

Scientists discover psychedelic drug 5-MeO-DMT induces a state of “paradoxical wake”

March 4, 2026
New research: AI models tend to reflect the political ideologies of their creators
Neuroimaging

Psilocybin produces different behavioral and brain-altering effects depending on the dose

February 26, 2026
Consumption of gluten harms the hypothalamus region of the brain in male mice and may lead to obesity, study finds
Ketamine

Ketamine blocks the short-term anxiety and social withdrawal linked to adolescent social defeat

February 25, 2026
The psychology behind society’s fixation on incels
Caffeine

Caffeine might ease anxiety and depression by calming brain inflammation

February 22, 2026
The psychology behind society’s fixation on incels
Ayahuasca

Scientists map the brain waves behind the intense effects of ayahuasca

February 22, 2026
A popular weight loss drug shows promise for treating alcohol addiction
Addiction

A popular weight loss drug shows promise for treating alcohol addiction

February 21, 2026

STAY CONNECTED

LATEST

Simple blood tests can detect dementia in underrepresented Latin American populations

Psychologists clash over the safety and effects of the cry it out parenting strategy

Exploring the motivations for cannabis use during sex

A single dose of cocoa flavanols improves cognitive performance during aerobic exercise

Standard mental health therapies often fall short for autistic adults, study suggests

Black employees struggle to thrive under managers perceived as Trump supporters

The psychological drive for structure predicts conspiracy thinking

Fascinating new research reveals your heart rate drops when your brain misperceives the world

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc